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D108013 A Multi-MenterPilotStudyofa SerpentineBalloon-ExpandableStent(beStentw):Acute
AngiographicandClinicalRaeulte
R. Beyar, J. Hamburger, A. Saaiman, A.L. Bartorelli, C. DiMario,
A. Colombo, C.W. Harem, C.J. White, P.W.Senuys for the Pilot beStent
Investigators. RambemHospital,Haifa,keel, Thorexcente6Rotterdam,
Netherlands
The beStent Isa new stainless steel balloon-expandable mesh stent which
hea a unique serpentine design. Rotation of the unique Iow-streeajunctions
upon expansion leads to orthogonal locking of the wires, maximizing radial
strength and assuring zero shortening. The stent has delineating gold mark-
ers which assure preeise positioning. We aim to present the initial acute
resulta in a pilot registty for stent evaluation. 264 stents were used in a total
of 217 patients (pte) (age 57.9+ 3.10; M-178; F-39) in 7 centers, for variable
indications. Stente of 15, 25 and 35 mm length were used. The arteries
treated were IAD (n = 112, 42%), Circumflex (n = 54, 20.2%), RCA (n = 95,
35.5%) left main (n = I, 0.4%), and vein graft (n = 5, 1.9%). Leaion types
were: A in 42 pts (16.5%); BI in 53 pts (20.7~o); B2 in 81 pte (31.8%); C in
79 pts (31Yo).159 pte required 1 Stt3flt, 40 pts required 2 Steflt$ and 18 pts
required 3 or more atente. Anticoegulation protocol included procedural hep-
arin with aspirin witWwithout ticlopidine. Smooth angiographic results were
obtained in all cases with no plaque hemiation. Acute angiogrephic success
was obtained in 99~o of the pts, and ‘dCUte ClifliCd success ifl 97.7% of the
pte. Complications were: 2 (0.92%), non-cardiac death; 2 (0.92%), mymr-
dial infarction; 2 (0.92%), stent thrombosis. Therefore, the beStent is useful
in treatment of complex lesions of variable length and complexity, providing
excellent acute results with a low complication rate, in spite of unfavorable
basic clinical and angiographic characteristics.
m study108014 PreliminaryReaultaof theCanadianCordieStent
L. Bilodeau, S. Doucet, R.G. Macdonald, B. O’Neill, L. Roy,J.-F. Marquis,
D.D. Almond, J. Burton, R. Brown, L Penn, J. Popma. MontrealHeart
Institute,Montreal,Quebec,Canada,SaintJohnRegionalHospital,
Saintdohn,NewBnmswick,Canada
The Cordis coronary stent is made of a single continuous tantalum wire
formed into a sinusoidal ribbon that is helically wound to form hoops along
the long axis of the device. This new stent design provides good flexibility
and radio-opacity.
Between December 1995 and June 1996, 115 pts with de novo (87%) or
reetenotic coronary lesion (13%) were treated with implafltatiOflof 1 (109 pts)
or multiple (6 pts) Cordis atents. In this cohort, the mean age was 57.8 & 9.4
y, 75.7% pts were male and 42.8% presentad with unstable angina. Target
vessel was the RCA in 30.5%, the LAD in 42.8% and the circumflex arteryin
28.9Y0of cases. Lesion types (ACC/AHA) were distributed as follow: 37.4%
type A, 33.9% type Bl, 27.0% type B2 and 0.9% type C. After stent delivety,
high preasure (Z 15 atm) intrastent inflation was systematically performed.
Postprocadure therapy consisted of aspirin and Ticlopidine. Successful stent
delive~’was achieved in 111out of 115 pts (96.5%). In hospital, no death
or Q-wave Ml were recorded but 2 patients suffered a non-Q wave ML At 1
month, only one patient needed repeat intervention.
Procedural quantitative coronary angiography available on the first SOpts
revealed a lesion length of 11.36 + 3.86 mm with an interpolated reference
diameter of 3.09*0.44 mm. Preprocedure, minimum lumen diameter (MLD)
was established at 0.94+0.39 mm. Postballoon prestent MLD reached 1.88
+0.35 mmandfinal instent MLDwasevaluatad at2.~+0.45mm. Disturbad
geomeby (uneven struts separation) afferfinal stent expansion wasobsefved
in 31.7%. Conclusion:The Cordis stent implantation for short de novo or
restenotic lesion seems to be feasible and safe. Visually assessed disturbed
stent geometty albeit frequent seem to be devoided of acute complication.
The acute and 6-month clinical and angiographic follow-up of the entire
cohort (115 pts) will be presented.
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IIiEEa QcAcompariaonofJ&JlscookFlaxatent$AvE
Micro StentandACSMultilink Stenta
E.V. Pomerantsev,C.P.Juergens, R.J. Whittmurn, A.C. Yeung,
S.N. Oesterle, S.H. Stertzer. StanfordUnivemityHospital,Stanford,CA,
USA
To compare mechanical properties of stents currently available in the USA,
we performed QCA assessment of minimal Iuminal diameter (MLD), lesion
length, and percent diameter stenosis (%D) pre and post procedure. Recoil
was defined as difference between balloon diameter (BD) and MLD post,
divided by BD. Palmaz-Schatz (P-S) consecutive stents (n = 88) were com-
pared with Gianturco-Roubin (G-R) (n= 25), AVE Micro Stents (n = 51) and
ACS Multilink (ML) stents (n = 6). There was no difference in lesion morphol-
ogy, reference diameters, baseline % D or Balloon/ArIety ratios. Baseline
MLD was sinallest in AVE compared to P-S group. Stentad segments were
longest in G-R and M-Lgroups. Residual Y. Dwas higher in G-R group, while
MLD was highest in AVE and P-S groups.
MLD Length % D ~st MLDPost Recoil,%
P-s 1.3 +0,5 12,2 & 4.5 7.6 &20.7 2.8* 0.6 24.6+ 13.0
G-R 1.1 l 0.7 20.7 k 5.8* 19.9 +23.S 2.3+ 0.6* 26.9+ 14.9
AVE 1.0 + o,4# tl .0 * 0.21 –4.8 & 21.81 2,8 + 0.61 25.9 + 15.0
ML 1.2 + 0.4 16.8 A 5.6& 5.9 l 5,9 2.7* 0.3 19.1 * 5.1’
*P-S vs. G-R p < 0,05; # P-S VS.AVE p < 0,05; IG-R VS.AVE p < 0.05; ‘AVE VS. ML p
< 0,05.
Deployment pressure was highest for P-S stents and lowest for AVE and
G-R (15.8 + 2.1 vs. 9.9 + 3.2 and 10.6+ 4.1 ATM respectively, p < 0.01).
Incidence of post stent dissections was higher for P-S and G-R groups (25
and 36%) and lowest for AVE (5.9’%., p c 0.01). Although amount of recoil
was similar in P-S, AVE and G-R groups, the pressure required to properly
deploy stents was different. In longer Iesionsthe use of G-R stents resulted in
higher % D and amaller MLD, suggesting necessity forpreliminaty debulking
or the use of different stenta.
m Stent108016 A NewDaliverySyatemfor the Palmaz-Schatz
C. Di Mario, B. Reimere, R. Reinhardt 1, T. Akiyama, M. Ferraro, 1.Mouesa,
S. Blengino, A. Colombo. ColumbusClinic,Milan,Italy 1J&J Interv
Systems,Warren,NJ,USA
The high profile and compliance of conventional stent delivery systems re-
quires large guiding catheters, aggressive predilatation and stent expansion
at high-pressure after delivery. Hand-crimping of the stent on non-compliant
PTCA balloons is increasingly used but this technique is hampered by the
risk of stent loss.
This study reports the first clinical application of a new non-compliant
ballcaI catheter deslgnedfor stentdelivery. The characteristics of the balloon
material (modified PET) are such that the Palmaz-Schatz stents become
deeply embedded and firmly attached to the balloon after hand-crimping.
Thirly-seven J&J stenta (3 x 6 mm, 22 x 14 mm, 2 x 20 mm and 8 x 30
mm) were implanted in 29 lesions (LAD: 45%, LCX: 24V0, RCA: 31%) of
23 patients. Stent implantation was immediately successful in 31/35 stents
(95%). In the two cases of complete failure of stent deployment, the stent
could not negotiate vety tortuous proximal vessels. Two other caees required
further predilatation or the use of a more rigid guide wire. In both cases, the
stent could be successfully withdrawn into the guiding catheter. At a mean
inflation pressure of 16 + 3 Atm (range 6-20) no balloon ruptures were
observed. Accurate positioning of the stant was facilitated by the 2 markers
at the balloon ends and by the optimal visualization after contrast injection,
even with 6 Fr guiding catheters (3 cases).
In conclusion, this new delivery system maintains all the advantages of
hand-crimped stents on non-compliant balloons minimizing the risk of stent
loss,
m108017 ArterialSealingDeviceAfterCoronaryStenting:Sewingor Anchoring?
B. Chevalier, V. Stratiev, B. Glatt, N. Diab, R. Bradai, T. Royer, P.Guyon.
CentreCardiologiqueduNerd,Sahrt-Denis,France
Percutaneous arterial suturing (PAS) (Tachstar’’”),using 2 brands of 3/0 su~
ture and Percutaneous arterial anchoring (PAA) (Angioseal””), with intravas-
cular anchor and collagen delivery, are new techniqws to close femoral
puncture s 8 F. In order to assess these two methoda after corona~ stent-
ing, we compared 2 consecutive series of pts treated at the end of the
precedure. Pts received a ticlopidine/aspirin drug regimen and were raised
at 4 hrs. Baselina clinical data were similar in both groups. All pts had early
and late clinical follow-up; vascular ultrasonography was systematically done
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at 24hours.
N (pts) 500
Timeplaoement(mh.) 5.6k 4
Manualpreseureues(%) 18
Compression>30 min.(%) 2
Hematoma(ailsize)(%) 5
Falseaneurysm(%) 1.6
Tmnsfusion(%) 1.2
Va.mularsurgew(%) 1.5
300
1,1 & 2 <0,001
25 <0,05
6 -=0.01
8 NS
2.5 NS
1.6 NS
2 NS
Thus, PAS has a slightly higher rate of immediate hemosteais than PAA,
with a more time-consuming placement. complication rate are Similady IOW
in both groups.
I 108O-18I Europ@*nFr-domStentRe*istV
l.K. De Soheerder, B. Chevalier, C. Va!$SaW. UWWSI!YHOSPMS,LeUVen,
Belgium
The Freedom’” stent (Globai Therapeutics, Inc.) isa new balloon expandable
coronary stent based on a high biocompatibilify 0.18 mm 316LVM stainleas
stwl wire, folded in bendad concentric loops, enabiing batter vessel align-
ment. Between November 1984 and August 1996, 1630 pts with 1726 lesions
were treated with 1923 stems In 16 centres. In 402 pte (24.7%) stents were
implanted as a bail-out procedur?, in 724 pte (44.4%) for optimalisation of a
suboptimal PTCA result, in 91 pts (5.6%) for treatment of recurrent resteno-
sis, and finaily in 413 pte (25.3%) as an elective procedure.
Anglographic success waeobtained in 15S1pts (97%). In-hoapitalcompli-
cations occurred in 72 pte (4.4%). Acute stent closure (-=24 h) n = 13 (0.8%),
subacute atent closure n = 7 (0.4%), AMi n = 12 (0.7%), emergency CABG
n = 13 (0.8%), death n = 5 (0.3’7.), major local complications n = 22 (1.3%).
Recurrence of angina pecforis anctlor a positive stress test during follow-up
occurred in 89 pts (5.47.). Systematic elective 6 m angiographlc follow-up
was performed in two Centres (n = 158 pts). Restenosis rSte (Z 50% DS)
was 26.8%, quantitative coronary analysls: minimal Iuminal diameter before
stenting: 1.01 + 0.93 mm, after stenting: 2.82 + 0.52 mm, at follow-up: 1.S8
+ 0.80 mm.
In conclusion: The Fraadom@intrecofonary stent can be placed suc-
cessfully in the majority of pts with a high rate of anglographic succass.
In-hospital complication rates were rare usin9 a Ticlopidin-AsPifin Prot.c.l.
Clinical follow-up wee favorable and the quantitative coronary analysis in
these non-selected coronaIy lesions revealad a restenosis rate of 26.6%.
C3108031 FrenchFreedomStentRegietry:MidtermReeulta
B. Chevalier, P. Montserrat, R. Huguet, P.Commaau, B. Lmcelin,
P.Dupouy, Y. Lienhart, L. Caster, O. Wittenberg, O. Tavolaro. Centre
Cardiologiqua du Nerd, Clinique Saint-Augustin, Saint-Denis, Bordeaux,
France
Thesafetyand efficeCyOfa newcoronary eoilatairleasateel atent (Freedomw)
wee aasessad by a retrospective atudy of consecutive early experiencaacoi-
Iected in 19 french centers. From 03/95 to OtYS8,1337 pts (18% women,
age: 62 +- 11y.) were treated on 1452 Iesiona using 1550 Freedom stems.
Artery diameter was 3.3 +– 0.5 mm; lesion was: A type 10Yo;B type 80?4.,C
type 30%. Lesion length was 15 +– 10 mm. Stent indication were: de novo
37%, restenosis 8%, sub-optimal resuit with dissection 38%, recoil 18% and
bail-out 3%. A 6 F sheath wee placed in 80% of oases; all pts received a
ticlopidinehzepirin drug regimen. Aftar infiation at 10.8 +- 2.4 atm. of a 3.4
+- 0.28 mm balloon to deploy the stent, final minimal Iuminal diameter was
3.1 +- 0.5 mm. Technical success was noted in 95.2%. Acute thrombcais (<
24 h) was noted in 1.1% and sub-acute thrombosis in 0.9%. Clinical success
rate was 88%; adverse eVentawere: Ml 1.5%, emergent CABG 0.7%, death
0.9% (inciuding acute Mi PTCA). Majof iocal mmplieetion rate was 1.6Y0.
In the first 470 pts, six months tafget late revaecularieation (TLR) rate was
11.5%. Predictive factors of TLR were: artery diameter -=2.5 mm, residual
stenosis > 20% and stent iength >25 mm.
Thua, in thia large multicenter registv, short and midterm reaults of Free-
dom stent implantation in mmplex ooronaty Ieaionsare satisfactory.
m108032 AreRandomizedTrialaNeceeeerytoAssessLong-TermOutcomewithNewDevicesfor
CoronaryIntervention?
D.L. Fischman, M.P. Savage, J. Brinker, C.J. Pepina, S. King, E. Topol,
R. Rake, D. Rehmann, S. Goldberg. Jefferson Medical College,
Philadelphia, PA, USA
Nonrandomized registries have provided obsawational data with respect to
Palmez-Schafz stent use in the treatment of atherosclerotic diaeaae in both
native coronary arteries and saphenous vein bypass grafts (SVG). There ie
increased pressure to utilize registry data in Iiau .of randomized trial data
due to logistic and economic concerns. The purpose of this analysis was to
compare restenosis ratas from tha JJIS stent regiatrles with randomized trials
STRESS (STent REStenosia Study) and SAVED (SAphenous VEin Denovo
triai). Similar inclusion and exclusion criteria, implantation technique, and
anticoagulation regimen were used In the regisby cohorts and corresponding
randomized trial. Quantitative angiographic analyses were performed by the
same core laboratory forall studies.Theresult6aresummarizedbeiow:
NATNS Svc
p -i.M4 p . esss
q I [ I
A
93. 3Z
an-
1:
1s
S*
14
1s
* la.
s-
*-7%
ns31wr3 STRSSS R,slmy SAVED
Thus, a significant discordance in restenosis rates was obsewed be-
tween registry and randomized studies despite similar inclusion criteria and
angiographic anaiysis by the same core laboratoV. These findings suggest
a bias In obsewatlonal registries predisposing toward favorable outcomes.
Prospective randomized trials are neeessay to assess the true efficacy of
new interventional devices.
-] AreSTRESSResul* Generaliable?The
NACI-PSSExperience
C.J. George, E.D. Kennard, R. Holubkov, K.M. Detfe. Univera/fy of
Piftsbugh, Pittsburgh, PA, USA
Of 522 NACi registry patiants receiving elective Palmatz-Schatz coronay
stents (PSS), 485 (93%) were STRESS ineligible (IPss),and 34 (7%) were
STRESSeiigible(EpS6).One yeaf events (lPSSvs. EPSS) were:DM = death
or myocardial infarction (14% vs. 8%), TLR = targat lesion revascuiarization
(22% vs. 9%), and D/MilTLR (31% VS.15%, p < 0.05). Adjustad reiative tisks
of one year events by presence of ineligibility criteria were as followe:
IneligibilityCriteria: % Prevalence DIMI Events Di?..tl/TLR
in NACI-PSS TLR
Poor EF (<35°,6) 4 1.8 1.1 t.3
Left Main Disease s 2.3** 1,6 2.2**
Ml <1 Week Prior 5 1.3 1,4 1.3
Restenotk Lesion 5s 0.7 1.5 1.2
Graft Vessel 44 1.5 0.8 1.1
Small RV (< 2.f mm) 3 f.1 0.8
LongLeaion(> 15 mm) 5 1.s 2.3* 2.6”*
LowStenosis(<55°/9) 6 1.6 1.0 1.1
Thrombus 6 1.9 1.1 1.8*
Tortuosify 3 1.3 1.4 1.2
DiffuseLesion 21 1.3 1.1 1.3
Ostial Leaion 2 2.3 3.3* 2.s”
EF = EjactionFraction,RV = Referancevessel, *p <0.05, **p <0.01
Conclusion: STRESS fesults may not generalize to the maj6rity of NACl-
PSS patients, especially those with left main disease, long lesions, lesions
with thrombus, or ostial lesions.
m108034 EvolvingTrendsinAngioplastyDeviceSelection:A NationalCardiovascularNetwork(NCN)
DatabaeaReport
E.D. Peteraon, A.J. Lansky, L.H. Muhlbaier, M.B. Leon, L. Navey,
M.J. Lenzilotta, J.J. Popma, L.F. Satler. Duke LAriversifyMedica/ Center,
Durham, NC, USA
Recent new device angioptasfy trials assessing the late clinical outcomes af-
ter stents, directional athefectomy (DCA), and rotational athefectomy (RA),
may influence intetventional operator strategies. To characterize these po-
tential effects, we reviewed serial trends in stent, DCA, and RA use between
1/94 and 12/95, using the NCN 41,684 patient dstabase from 18 nationwide
high-volume interventional centers. Serial trends are shown below (Figure&
Table),
